TipRanks
Pharming Group (PHAR)
NASDAQ:PHAR
US Market
PHAR
Pharming Group
RESEARCH TOOLSreports
Want to see PHAR full AI Analyst Report?

Pharming Group (PHAR) Income Statement

240 Followers

Pharming Group Income Statement

Last quarter (Q2 2026), Pharming Group's total revenue was €90.21M, a decrease of -3.23% from the same quarter last year. In Q2, Pharming Group's net income was €1.64M. See Pharming Group’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 376.13M$ 297.20M$ 245.32M$ 205.62M$ 198.87M
Gross Profit
$ 330.63M$ 261.80M$ 220.10M$ 188.06M$ 177.73M
Operating Expenses
$ 309.75M$ 265.47M$ 242.39M$ 178.20M$ 158.72M
Depreciation and Amortization
$ 11.22M$ 16.07M$ 15.93M$ 13.19M$ 19.61M
EBITDA
$ 34.78M$ 16.32M$ 9.88M$ 33.53M$ 48.78M
Operating Income
$ 20.88M$ -3.67M$ -22.29M$ 9.86M$ 19.01M
Other Income/Expenses
$ -8.03M$ -4.83M$ 10.28M$ 5.13M$ 4.07M
Pretax Income
$ 12.85M$ -8.49M$ -12.01M$ 14.99M$ 23.08M
Net Income
$ 2.85M$ -11.84M$ -10.55M$ 13.67M$ 16.00M
Per Share Metrics
Basic EPS
$ 0.04$ -0.18$ -0.14$ 0.17$ 0.23
Diluted EPS
$ 0.04$ -0.18$ -0.14$ 0.16$ 0.21
Weighted Average Shares Outstanding
 71.32M 68.92M 65.70M 82.54M 87.64M
Weighted Average Shares Outstanding (Diluted)
 71.32M 68.92M 65.70M 84.28M 87.64M

Pharming Group Earnings and Revenue History